NCT01493388View on ClinicalTrials.gov

To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1

CompletedOBSERVATIONAL

Enrollment

402

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin

Patients will be treated according to routine clinical practice at the discretion of the treating physician.

Trial Locations (1)

1053

Novo Nordisk Investigational Site, Tunisia

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY